When is Canada launching new Covid vaccines targeting KP.2 variant? All you want to know

Health Canada is assessing new COVID-19 vaccines from Pfizer, Moderna, and Novavax targeting emerging Omicron subvariants, including KP.2, following U.S. approvals. These vaccines address waning immunity and the spread of new variants, posing risks, especially to vulnerable populations. Launch is expected post-review for fall and winter vaccination campaigns.